In particular, the administration of granulocyte colony stimulating factors (G-CSF) after stem cell infusion permitted a faster neutrophil number recovery and consequent drop in febrile neutropenia events, infection occurrence, antibiotic use, and hospital stay days [4]. This evidence concerns the gene CSF3 and neutropenia.